These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 9108466

  • 1. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J.
    Cancer Res; 1997 Apr 15; 57(8):1597-604. PubMed ID: 9108466
    [Abstract] [Full Text] [Related]

  • 2. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, Teixeira MR.
    Breast Cancer Res Treat; 2007 Apr 15; 102(2):143-55. PubMed ID: 16906480
    [Abstract] [Full Text] [Related]

  • 3. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 4. Molecular cytogenetics of primary breast cancer by CGH.
    Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP.
    Genes Chromosomes Cancer; 1998 Mar 01; 21(3):177-84. PubMed ID: 9523192
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.
    Walch AK, Zitzelsberger HF, Bink K, Hutzler P, Bruch J, Braselmann H, Aubele MM, Mueller J, Stein H, Siewert JR, Höfler H, Werner M.
    Mod Pathol; 2000 Jul 01; 13(7):814-24. PubMed ID: 10912943
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schröder FH, van der Kwast TH, Bosman FT, van Dekken H.
    Lab Invest; 1997 Nov 01; 77(5):437-48. PubMed ID: 9389787
    [Abstract] [Full Text] [Related]

  • 11. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY, Yu JC, Lo YL, Kuo CH, Yue CT, Jou YS, Huang CS, Lung JC, Wu CW.
    Cancer Res; 2000 Jul 15; 60(14):3884-92. PubMed ID: 10919664
    [Abstract] [Full Text] [Related]

  • 12. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J, Hirasawa K, Bostwick DG, Bergstralh EJ, Slezak JM, Anderl KL, Borell TJ, Lieber MM, Jenkins RB.
    Mod Pathol; 2002 Jan 15; 15(1):35-44. PubMed ID: 11796839
    [Abstract] [Full Text] [Related]

  • 13. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD, Syrrou M, Georgiou I, Pagoulatos G, Agnantis NJ.
    J Exp Clin Cancer Res; 1999 Sep 15; 18(3):357-61. PubMed ID: 10606182
    [Abstract] [Full Text] [Related]

  • 14. Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
    Bonsing BA, Devilee P, Cleton-Jansen AM, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ.
    Cancer Res; 1993 Aug 15; 53(16):3804-11. PubMed ID: 8101767
    [Abstract] [Full Text] [Related]

  • 15. Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.
    Riener MO, Nikolopoulos E, Herr A, Wild PJ, Hausmann M, Wiech T, Orlowska-Volk M, Lassmann S, Walch A, Werner M.
    Hum Pathol; 2008 Nov 15; 39(11):1621-9. PubMed ID: 18656243
    [Abstract] [Full Text] [Related]

  • 16. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NC, Pintilie M, Miller N, Youngson B, McCready DR, Done SJ.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1091-101. PubMed ID: 19760610
    [Abstract] [Full Text] [Related]

  • 17. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.
    Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo WL.
    Cancer Res; 1994 Aug 15; 54(16):4257-60. PubMed ID: 8044767
    [Abstract] [Full Text] [Related]

  • 18. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.
    Am J Surg Pathol; 2009 Apr 15; 33(4):496-504. PubMed ID: 19047897
    [Abstract] [Full Text] [Related]

  • 19. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
    Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S.
    Cancer Res; 1996 Feb 15; 56(4):855-9. PubMed ID: 8631024
    [Abstract] [Full Text] [Related]

  • 20. Unusual clonal chromosomal evolution in a breast carcinoma and its lymph node metastasis in a patient with Down syndrome.
    Bernardino J, Gerbault-Seureau M, Sastre X, Dutrillaux B.
    Genes Chromosomes Cancer; 1997 Jul 15; 19(3):195-9. PubMed ID: 9219002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.